Upstate Active Clinical Trials Seeking Participants
Comparative Study of the Diagnostic Accuracy of Scintimammography (Technetium 99m-Sestamibi and Fluorine 18-FDG PET Scintigraphic Imaging) and Magnetic Resonance Imaging in Identifying Malignant Breast Lesions, in Subjects with Breast Abnormalities.
What is the purpose of the study?
Due to x-ray mammograms being difficult to interpret, this study will determine the diagnostic accuracy of breast Magnetic Resonance Imaging and Nuclear Medicine (including) PET imaging.
Who is eligible?
Difficult to interpret or non-interpretable mammogram (usually due to dense tissue in the breasts).
What is involved if I participate?
- How long is the study?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
Nuclear medicine breast imaging, PET scan, magnetic resonance study.
Who is the doctor administering the study?
David Feiglin, M.D.
Where will the study take place?
SUNY Upstate Medical University, Syracuse, NY
Over what time period is the study scheduled to run?
Who can I contact for more information?
- Name: Sue Hemingway
- Phone: (315) 464-5099
- Email: Hemingws@upstate.edu
- Fax: (315) 464-5080
If you are interested in this trial, please contact the study coordinator or investigator noted above.